Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways

被引:41
|
作者
Gonzalez-Fernandez, Rebeca [2 ]
Pena, Oscar [2 ]
Hernandez, Jairo [1 ]
Martin-Vasallo, Pablo [2 ,3 ]
Palumbo, Angela [1 ,4 ]
Avila, Julio [2 ,3 ]
机构
[1] Ctr Asistencia Reprod Humana Canarias, San Cristobal la Laguna, Spain
[2] Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Spain
[3] Univ La Laguna, Inst Tecnol Biomed, Tenerife, Spain
[4] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA
关键词
Granulosa-lutein cells; PAPP and CYP19A1 genes; in vitro fertilization; FSHR pathway signaling; RAT GRANULOSA-CELLS; MOLECULAR-BIOLOGY; GENE-EXPRESSION; FSH RECEPTOR; PROTEIN; GROWTH; ACTIVATION; INDUCTION; ESTRADIOL; AROMATASE;
D O I
10.1016/j.fertnstert.2011.03.030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the integrity of the FSH receptor (FSHR) signaling pathway in granulosa-lutein cells at the time of egg retrieval and its relationship with the infertility diagnosis. Design: In vitro assays. Setting: University laboratory and private IVF center. Patient(s): Patients undergoing IVF: 35 controls (no ovarian factor, NOF), 28 poor responders (PR), 32 patients with endometriosis (EM), and 22 patients with polycystic ovary syndrome (PCOS). Intervention(s): Quantitative reverse transcriptase-polymerase chain reaction (PCR) in granulosa-lutein cells from pooled follicles. Main Outcome Measure(s): Correlation between expression of FSHR and FSH-regulated genes PAPP/Cyp19A1. Result(s): Positive correlations among FSHR, PAPP, and Cyp19A1 expression levels are observed in NOF and are lost, with different patterns, in poor responder patients and those with endometriosis. Patients with endometriosis are an heterogeneous group including patients with poor ovarian reserve who behave like other poor responders patients (endometriosis-A) and patients with good response to ovarian stimulation (endometriosis-B) who show a specific alteration of the FSHR signaling pathway. Conclusion(s): These preliminary data suggest that the different signaling pathways activated through the FSHR in normal ovaries (NOF) are disrupted in poor responders and in patients with endometriosis. Abetter knowledge of the molecular origin of these errors may guide clinicians in the choice of personalized ovulation induction protocols for each type of ovarian dysfunction. (Fertil Steril (R) 2011; 95: 2373-8. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码:2373 / 2378
页数:6
相关论文
共 50 条
  • [31] Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin
    Meo, F
    Ranieri, DM
    Khadum, I
    Serhal, P
    FERTILITY AND STERILITY, 2002, 77 (03) : 630 - 632
  • [32] Follicle-stimulating hormone regulates expression and activity of epidermal growth factor receptor in the murine ovarian follicle
    El-Hayek, Stephany
    Demeestere, Isabelle
    Clarke, Hugh J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (47) : 16778 - 16783
  • [33] Regulation of follicle-stimulating and luteinizing hormone receptor signaling by "regulator of G protein signaling" proteins
    Castro-Fernández, C
    Maya-Núñez, G
    Méndez, JP
    ENDOCRINE, 2004, 25 (01) : 49 - 54
  • [34] Regulation of follicle-stimulating and luteinizing hormone receptor signaling by “regulator of G protein signaling” proteins
    C. Castro-Fernández
    G. Maya-Núñez
    J. P. Méndez
    Endocrine, 2004, 25 : 49 - 54
  • [35] A mutant single nucleotide polymorphism of follicle-stimulating hormone receptor is associated with a lower risk of endometriosis
    Wang, Hsin-Shih
    Cheng, Bi-Hwa
    Wu, Hsien-Ming
    Yen, Chih-Feng
    Liu, Chun-Ting
    Chao, Angel
    Wang, Tzu-Hao
    FERTILITY AND STERILITY, 2011, 95 (01) : 455 - 457
  • [36] Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility
    Bose, Chinmoy K.
    CARCINOGENESIS, 2007, 28 (09) : 2059 - 2059
  • [37] Development of Lipid Nanoparticles Targeting the Follicle-Stimulating Hormone Receptor in Ovarian Cancer.
    Dalmau, Ester Barau
    Butler, Trent
    Paul, Jonathan W.
    Gebeh, Alpha
    Somanathan, Nandini
    Smith, Roger
    Tolosa, Jorge M.
    REPRODUCTIVE SCIENCES, 2024, 31 : 154A - 154A
  • [38] Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype
    Mayorga, MP
    Gromoll, J
    Behre, HM
    Gassner, C
    Nieschlag, E
    Simoni, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09): : 3365 - 3369
  • [39] Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube
    Zheng, WX
    Magid, MS
    Kramer, EE
    Chen, YT
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (01): : 47 - 53
  • [40] Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles
    Oktay, K
    Briggs, D
    Gosden, RG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11): : 3748 - 3751